Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA137871 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus
| PRJNA596338 | ENA
Project description:Genomic aberrations predicts survival in clear cell renal cell carcinoma
| PRJNA143551 | ENA
Project description:LncRNA from metastatic clear cell renal cell carcinoma (ccRCC) compared with non-metastatic clear cell renal carcinoma
| PRJNA349174 | ENA
Project description:Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic
| PRJNA174040 | ENA
Project description:Clear cell and chromophobe renal cell carcinoma samples
| PRJNA118347 | ENA
Project description:Recent insights into the role of the VHL tumor suppressor gene in hereditary and sporadic clear cell carcinoma of the kidney (ccRCC) have led to new treatments for patients with metastatic ccRCC, although virtually all patients eventually succumb to the disease. We performed an integrated, genome-wide analysis of copy-number changes and gene expression profiles in 90 tumors, including both sporadic and VHL disease-associated tumors, in hopes of identifying new therapeutic targets in ccRCC. We identified 14 regions of nonrandom copy-number change, including 7 regions of amplification (1q, 2q, 5q, 7q, 8q, 12p, and 20q) and 7 regions of deletion (1p, 3p, 4q, 6q, 8p, 9p, and 14q). An analysis aimed at identifying the relevant genes revealed VHL as one of 3 genes in the 3p deletion peak, CDKN2A and CDKN2B as the only genes in the 9p deletion peak, and MYC as the only gene in the 8q amplification peak. An integrated analysis to identify genes in amplification peaks that are consistently overexpressed among amplified samples confirmed MYC as a potential target of 8q amplification and identified candidate oncogenes in the other regions. A comparison of genomic profiles revealed that VHL disease-associated tumors are similar to a subgroup of sporadic tumors, and thus more homogeneous overall. Sporadic tumors without evidence of biallelic VHL inactivation fell into 2 groups: one group with genomic profiles highly dissimilar to the majority of ccRCC, and a second group with genomic profiles that are much more similar to tumors with biallelic inactivation of VHL. Keywords: comparative genomic hybridization 90 clear cell renal cell carcinomas and 21 renal cancer cell lines were subject to 250K SNP analysis.
2010-04-10 | E-GEOD-14994 | biostudies-arrayexpress
Project description:microRNA profiling in primary clear cell renal cell carcinoma
| PRJNA131881 | ENA
Project description:MicroRNA expression of clear cell papillary renal cell carcinoma
| PRJNA223405 | ENA
Project description:Expression data of human clear cell renal cell carcinoma
| PRJNA352477 | ENA
Project description:Genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus
| PRJNA596359 | ENA